ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!PASG Company Profile and Key Details
Passage Bio, Inc.
PASG Stock Price Chart
Stock Price Today
Passage Bio, Inc. (PASG) stock declined over -7.34%, trading at $0.48 on NASDAQ, down from the previous close of $0.52. The stock opened at $0.52, fluctuating between $0.48 and $0.53 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD-GRN; and PBKR03, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company also develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and PBCM06 for the treatment of Charcot-Marie-Tooth Type 2A. Passage Bio, Inc. has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Company Information
| Employees | 58 |
| Beta | 1.54 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Passage Bio, Inc. (NASDAQ: PASG) stock price is $0.48 in the last trading session. During the trading session, PASG stock reached the peak price of $0.53 while $0.48 was the lowest point it dropped to. The percentage change in PASG stock occurred in the recent session was -7.34% while the dollar amount for the price change in PASG stock was -$0.04.
The NASDAQ listed PASG is part of Biotechnology industry that operates in the broader Healthcare sector. Passage Bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Simona King
Chief Financial Officer & Corporation Sec.
David Weinstein M.D.
Senior Vice President of Clinical Devel.
Dr. William Chou M.D.
Pres, Chief Executive Officer & Director
Mr. Edgar B. Cale Esq., J.D.
Gen. Counsel & Company Sec.
Gregory Fuest
Vice President of Global Commercial Strategy & Marketing
Dr. Mark Forman M.D., Ph.D.
Chief Medical Officer
Dr. James M. Wilson M.D., Ph.D.
Co-Founder & Chief Scientific Advisor
Mr. Alexandros Fotopoulos MBA, MSc
Chief Technical Officer
Mr. Stuart M. Henderson
Senior Vice President of Corporation Devel. & Investor Relations
Desiree Luthman D.D.S.
Senior Vice President of Global Regulatory Affairs
Dr. Desiree Luthman D.D.S.
Senior Vice President of Global Regulatory Affairs
Ms. Kathleen Borthwick
Senior Vice President of Fin., Principal Accounting Officer & Interim Chief Financial Officer
Eden Fucci
Senior Vice President of Technical Operations
PASG's closing price is 6.43% higher than its 52-week low of $0.45 where as its distance from 52-week high of $1.79 is -73.18%.
Number of PASG employees currently stands at 58.
Official Website of PASG is: https://www.passagebio.com
PASG could be contacted at phone 267 866 0311 and can also be accessed through its website. PASG operates from One Commerce Square, Philadelphia, PA 19103, United States.
PASG stock volume for the day was 217.38K shares. The average number of PASG shares traded daily for last 3 months was 424.36K.
The market value of PASG currently stands at $29.65M with its latest stock price at $0.48 and 61.77M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com